MiR-340 Is a Biomarker for Selecting Treatment Between Chemotherapy and Allogeneic Transplantation in Acute Myeloid Leukemia

por Niu, Mingshan, Zhang, Ninghan, Wang, Rong, Shao, Tingting, Feng, Yuan, Shen, Yangling, Liu, Xuejiao, Zhao, Kai, Zhu, Shengyun, Xu, Linyan, Yao, Yao, Xu, Kailin
Publicado 2019

High expression of miR-25 predicts favorable chemotherapy outcome in patients with acute myeloid leukemia

por Niu, Mingshan, Feng, Yuan, Zhang, Ninghan, Shao, Tingting, Zhang, Huihui, Wang, Rong, Yao, Yao, Yao, Ruosi, Wu, Qingyun, Cao, Jiang, Liu, Xuejiao, Liu, Yubo, Xu, Kailin
Publicado 2019

High expression of miR-363 predicts poor prognosis and guides treatment selection in acute myeloid leukemia

por Zhang, Huihui, Zhang, Ninghan, Wang, Rong, Shao, Tingting, Feng, Yuan, Yao, Yao, Wu, Qingyun, Zhu, Shengyun, Cao, Jiang, Zhang, Huanxin, Li, Zhenyu, Liu, Xuejiao, Niu, Mingshan, Xu, Kailin
Publicado 2019

MALT1 Inhibition as a Therapeutic Strategy in T-Cell Acute Lymphoblastic Leukemia by Blocking Notch1-Induced NF-κB Activation

por Wang, Rong, Zhang, Huihui, Xu, Jiawen, Zhang, Ninghan, Pan, Ting, Zhong, Xiaomin, Zhang, Huanxin, Yin, Lingling, Yao, Yao, Wu, Qingyun, Li, Zhenyu, Liu, Xuejiao, Xu, Kailin, Niu, Mingshan
Publicado 2020

MiR-425 expression profiling in acute myeloid leukemia might guide the treatment choice between allogeneic transplantation and chemotherapy

por Yang, Chen, Shao, Tingting, Zhang, Huihui, Zhang, Ninghan, Shi, Xiaoying, Liu, Xuejiao, Yao, Yao, Xu, Linyan, Zhu, Shengyun, Cao, Jiang, Cheng, Hai, Yan, Zhiling, Li, Zhenyu, Niu, Mingshan, Xu, Kailin
Publicado 2018